Counterfeit Keytruda (pembrolizumab), an immunotherapy cancer treatment, has infiltrated pharmaceutical supply chains and reached patients and hospitals. The fake medications pose potentially fatal consequences for cancer patients depending on authentic treatment, indicating significant health system vulnerability to pharmaceutical fraud.

The World Food Programme reports a significant funding shortfall that could result in cuts to humanitarian aid in Sudan within weeks as famine conditions worsen. More families across Sudan are being pushed toward famine as international support mechanisms face resource constraints.

WHO Director General Tedros Adhanom Ghebreyesus states that attacks on health care have become the 'new normal' of conflict, highlighting a concerning trend of deliberate targeting of healthcare infrastructure, facilities, and personnel during armed conflicts worldwide.